SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Inhibikase Therapeutics, Inc. (NASDAQ: IKT)
Provided By PR Newswire
Last update: May 5, 2025
NEW YORK, May 5, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Inhibikase Therapeutics, Inc. (NASDAQ: IKT) on behalf of the company's shareholders. The investigation seeks to determine whether Inhibikase Therapeutics's directors breached their fiduciary duties in connection with recent corporate actions.
Read more at prnewswire.com
